- Presentations
- 3
- Markets
- 1
Qulipta is a brand of Atogepant marketed by AbbVie, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Atogepant
- Brand owner
- AbbVie
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 30 mg tablet, 60 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Qulipta 10 mg tabletOral | AbbVie | US FDA | Available on request |
| Qulipta 30 mg tabletOral | AbbVie | US FDA | Available on request |
| Qulipta 60 mg tabletOral | AbbVie | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Qulipta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.